JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Effects of Weekly Administration of Implant-type Recombinant Porcine Somatotropin on the Performance and Carcass Characteristics of Finishing Pigs
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Effects of Weekly Administration of Implant-type Recombinant Porcine Somatotropin on the Performance and Carcass Characteristics of Finishing Pigs
Kim, Y.H.; Jung, H.J.; Park, J.C.; Kwon, O.S.; Chung, C.S.; Ko, Y.D.; Moon, H.K.;
  PDF(new window)
 Abstract
The present study was undertaken to investigate the effects of weekly administration of implant type recombinant porcine somatotropin (rpST) on the performance and carcass characteristics in finishing pigs. A total of 120 crossbred (LandraceYorkshireDuroc) pigs were employed for 11 weeks in a growth trial in experiment. A rpST designed to implant every 7 d was used. Forty pigs, each weighing 75 kg, were allocated into three rpST treatments; control (CONT), implant of rpST from 75 kg (TRT1) or 90 kg (TRT2) of body weight. The CONT pig and pigs in TRT2 from 75 kg to 90 kg were treated without rpST but with placebo. In rpST-treated pigs, each 100 mg and 125 mg of the equivalent rpST was implanted from live weight of 75 kg to 90 kg and from 90 kg to market weight, respectively. Half of the pigs from each treatment were marketed at live weight of 110 kg and the rest at 130 kg. All pigs were allowed ad libitum access to a commercial feed containing 0.94% and 0.88% of lysine from 75 to 110 kg, 110 to 130 kg of body weights, respectively. rpST had no effect on daily gain, while feed efficiency was improved by 7 to 13% (p<0.05) in the rpST-treated groups compared with the CONT. Compared with the CONT, backfat thickness was decreased by 12% (p<0.05) in TRT1 at 110 kg of market weight, and by 23 to 32% (p<0.05) in the rpST-treated groups at 130 kg of market weight, respectively. Lean muscle rate tended to be higher in TRT1 at both 110 kg and 130 kg of market weight, and carcass fat percentage in the rpST-treated groups was decreased by 33 to 46% (p<0.05) compared with the CONT.
 Keywords
Recombinant Porcine Somatotropin;Growth Performance;Carcass Quality;Hormones;Finishing Pigs;
 Language
English
 Cited by
 References
1.
Azain,M. J., K. D. Bullock, T. R. Kasser and J. J. Veenhuizen. 1992. Relationship of mode of porcine somatotropin administration and dietary fat to the growth performance and carcass characteristics of finishing pigs. J. Anim. Sci. 70:3086-3095.

2.
Azain, M. J., D. B. Hausman, T. R. Kasser and R. J. Martin. 1995. Effect of somatotropin and feed restriction on body composition and adipose tissue metabolism in obese Zucker rats. Am. J. Physiol. 269:E137-E144.

3.
Becker, B. A., C. D. Knight, F. C. Buonomo, G. W. Jesse, H. B. Hedrick and C. A. Baile. 1992. Effect of a hot environment on performance, carcass characteristics, and blood hormones and metabolites of pigs treated with porcine somatotropin. J. Anim. Sci. 70:2732-2740.

4.
Bidanel, J. P., M. Bonneau, A. Pointillart, J. Gruand, J. Mourot and I. Demade. 1991. Effects of exogenous porcine somatotropin (pST) administration on growth performance, carcass traits, and pork meat quality of Meishan, Pietrain and crossbred gilts. J. Anim. Sci. 69:3511-3522.

5.
Boyd, R. D. and D. E. Bauman. 1989. Mechanisms of action for somatotropin in growth. In: (Ed. D. R. Campion, G. J. Hausman and R. J. Martin) Current concepts of animal growth regulation. pp. 257-293. Plenum Publishing, New York.

6.
Boyd, R. D., D. E. Bauman, D. G. Fox and C. Scanes. 1991. Impact of metabolism modifiers on protein accretion and protein and energy requirements of livestock. J. Anim. Sci. 69 (Suppl):2:56-75.

7.
Choi, M. J., J. E. Choi, J. S. Park, I. S. Kim, J. S. Keel and C. S. Chung. 1993. Effect of recombinant porcine somatotropin (rPST) administration on residual PST and insulin-like growth factor-1 levels in tissues and sera of pigs. J. Food Hyg. Soc. Japan. 34:136-141.

8.
Chung, C. S., T. D. Etherton and J. P. Wiggins. 1985. Stimulation of swine growth by porcine growth hormone. J. Anim. Sci. 60:118-130.

9.
Campbell, R. G., N. C. Steele, T. J. Caperna, J. P. McMurtry and M. B. Solomon. 1988. Interrelationships between energy intake and endogenous porcine growth hormone administration on the performance, body composition and protein and energy metabolism of growing pigs weighting 25 to 55 kilograms live weight. J. Anim. Sci. 66:1643-1655.

10.
Campbell, R. G., R. J. Johnson and R. H. King. 1989a. Implications of biotechnological techniques for manipulating animal growth and development on tissue and dietary nutrient requirements of pigs. In: (Ed. P. van der Wall, G. J. Nieuwhof and R. D. Politiek). Biotechnology for control of growth and product quality in swine: Implication and acceptability. pp. 137-144. Pudoc Publishing Co., Wageningen, The Netherlands.

11.
Campbell, R. G., N. C. Steele, T. J. Caperna, J. P. McMurtry, M. B. Solomon and A. D. Mitchell. 1989b. Effects of exogenous porcine growth hormone administration between 30 and 60 kilograms on the subsequent and overall performance of pigs grown to 90 kilograms. J. Anim Sci. 67:1265-1271.

12.
Dunshea, F. R., D. M. Harris, D. E. Bauman, R. D. Boyd and A. W. Bell. 1992. Effect of porcine somatotropin on in vivo glucose kinetics and lipogenesis in growing pigs. J. Anim. Sci. 70:141-151.

13.
Eisemann, J. H., A. C. Hammond, T. S. Rumsey and D. E. Bauman. 1989. Nitrogen and protein metabolism and metabolites in plasma and urine of beef steers treated with somatotropin. J. Anim. Sci. 67:105.

14.
Etherton, T. D., J. P. Wiggins, C. S. Chung, C. M. Evock, J. F. Rebhun and P. E. Walton. 1986. Stimulation of pig growth performance by porcine growth hormone and growth hormone-releasing factor. J. Anim. Sci. 63:1389-1399.

15.
Etherton, T. D., J. P. Wiggins, C. M. Evock, C. S. Chung, J. F. Rebhun, P. E. Walton and N. C. Steele. 1987. Stimulation of pig growth performance by porcine growth hormone: determination of the dose-response relationship. J. Anim. Sci. 64:433-443.

16.
Evans, F. D., V. R. Osborne, N. M. Evans, J. R. Morris and R. R. Hacker. 1991. Effect of different patterns of administration of recombinant porcine somatotropin on growth performance and economic returns of pigs in the starter vs. finisher phase of production. Can. J. Anim. Sci. 71:355.

17.
Evock, C. M., T. D. Etherton, C. S. Chung and R. E. Ivy. 1988. Pituitary porcine growth hormone (pGH) and a recombinant pGH analog stimulate pig growth performance in a similar manner. J. Anim. Sci. 66:1928-1941.

18.
Groesbeck, M., A. Parlow and W. Daughaday. 1987. Stimulation of supranormal growth in prepubertal, adult plateaued and hypophysectomized female rats by large doses of rat growth hormone: physiological effects and adverse consequences. Endorinology. 120:R380-R386.

19.
Hacker, R. R., A. Deschutter, O. Adeola and T. R. Kasser. 1993. Evaluation of long-term somatotropin implants in finishing pigs. J. Anim. Sci. 71:564-570.

20.
Jones, R. W., R. A. Easter, F. K. McKeith, R. H. Dalrymple, H. M. Maddock and J. Bechtel. 1985. Effect of $\beta$-adrenergic agonist cimaterol (CL263,780) on the growth and carcass characteristics of finishing swine. J. Anim. Sci. 61:905.

21.
Knight, C. D., T. R. Kasser, G. H. Swenson, R. L. Hintz, M. Z. Azain, R. O. Bates, T. R. Cline, J. D. Crenshaw, G. L. Cromwell, H. B. Hedrick, S. J. Jones, D. H. Kropf, A. J. Lewis, D. C. Mahan, F. M. McFeith, C. L. McLaughlin, J. L. Nelssen, J. E. Novakofski, M. W. Orcutt and N. A. Parrett. 1991. The performance and carcass composition responses of finishing swine to a range of porcine somatotropin doses in a 1-week delivery system. J. Anim. Sci. 69:4678-4689.

22.
Lee, K. C., M. J. Azain, M. D. Hardin and S. E. Williams. 1994. Effect of porcine somatotropin (pST) treatment and withdrawl on performance and adipose tissue cellularity in finishing swine. J. Anim. Sci. 72:1702-1711.

23.
Machlin, L. J. 1972. Effect of porcine growth hormone on growth and carcass composition of the pig. J. Anim. Sci. 35:794-800.

24.
Mikel, W. B., T. G. Althen, R. W. Rogers, A. B. Moore, H. W. Miller and L. F. Miller. 1993. Effects of exogenous porcine somatotropin on the carcass composition, hormonal and metabolic profiles, lipogenic capacity, and binding of insulin to erythrocyte receptors of fast- versus slow-growing swine. J. Anim. Sci. 71:1786-1795.

25.
Smith, V. G. and C. W. Kasson. 1990. Growth performance and carcass characteristics of pigs administered recombinant porcine somatotropin during 30 to 110 kilogram live weight. J. Anim. Sci. 68:4109-4116.

26.
Steele, N. C., R. Campbell, T. Caperna, M. Solomon and A. D. Mitchell. 1988. Nutrient partitioning in swine: Sustained benefit from porcine growth hormone administration. Fed. Am. Soc. Exp. Biol. 72$^{nd}$ Annu. Mtg., Abstr. #772.

27.
Steele, N. C., R. Campbell, T. Caperna, J. P. McMurty and M. B. Solomon. 1989. pST efficacy in North America: Management variables and advantages. In: (Ed. P. van der Wall, G. J. Nieuwhof and R. D. Politiek). Biotechnology for control of growth and product quality in swine: Implication and acceptability. pp. 51-63. Pudoc Publishing Co., Wageningen, The Netherlands.

28.
Walton, P. E., T. D. Etherton and C. S. Chung. 1987. Exogenous pituitary and recombinant growth hormone induce insulin and insulin-like growth factor-1 resistance in pig adipose tissue. Dom. Anim. Endocrinol. 4:183-189.

29.
Wray-Cahen, D., D. A. Ross, D. E. Bauman and R. D. Boyd. 1991. Metabolic effects of porcine somatotropin: Nitrogen and energy balance and characterization of the temporal pattern of blood metabolites and hormones. J. Anim. Sci. 69:1503.